Parmax Pharma Financials

BSE: 540359

₹135.10

up-down-arrow ₹0.10 (0.07%)

As on 16-Nov-2026IST

Market cap

info icon

₹93 Cr

Revenue (TTM)

info icon

₹28 Cr

P/E Ratio

info icon

87.9

P/B Ratio

info icon

11.4

Div. Yield

info icon

0 %

Income Statement (₹ Cr)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Operating Revenue
27.56
12.11
28.20
11.05
15.40
18.24
Total Income
31.92
12.16
28.24
11.10
15.44
18.31
Total Expenditure
29.84
15.75
27.95
14.42
13.14
15.68
EBITDA
-2.28
-3.64
0.25
-3.37
2.26
2.56
Depreciation
1.49
1.01
1.03
1.71
1.88
1.93
EBIT
-3.76
-4.65
-0.78
-5.08
0.38
0.63
Interest
1.23
1.24
0.59
0.62
0.37
0.39
Other Income
4.36
0.05
0.04
0.05
0.04
0.06
Exceptional Items
--
--
-1.07
--
--
--
Profit before Tax
-0.63
-5.85
-2.40
-5.66
0.05
0.30
Provision for Tax
-1.69
-1.69
-0.30
0.09
0.15
0.16
Profit after Tax
1.06
-4.16
-2.09
-5.75
-0.10
0.14

Liabilities (₹ Cr)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Shareholder's Funds
9.37
-6.15
-1.99
0.11
5.86
5.96
Minority Interest
--
--
--
--
--
--
Non-Current Liabilities
11.03
9.64
7.51
6.01
4.62
4.70
Current Liabilities
17.66
22.68
13.04
9.21
7.14
7.31
Total Liabilities
38.05
28.05
18.75
15.33
17.61
17.97

Assets (₹ Cr)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Non-Current Assets
13.21
9.49
9.62
9.56
9.69
10.62
Current Assets
24.85
16.68
8.94
5.77
7.53
6.56
Total Assets
38.05
28.05
18.75
15.33
17.61
17.97
Total Debt*
--
12.06
8.09
5.91
5.37
5.18
Net Current Assets
7.19
-6.00
-4.10
-3.44
0.39
-0.75
Contingent Liabilities
--
--
--
1.00
1.00
1.00

Cashflow (₹ Cr)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Cash From Operating Activities
--
-2.36
-0.66
-0.20
0.33
0.75
Cash Flow from Investing Activities
--
-0.90
-0.70
-1.59
-0.94
-1.53
Cash from Financing Activities
--
3.81
1.40
1.43
-0.04
-0.91
Net Cash Inflow / Outflow
--
0.56
0.04
-0.36
-0.65
-1.69

Financials Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Adjusted EPS (₹) info
2.62
-11.12
-5.60
-15.37
-0.28
0.38
Cash EPS (₹) info
--
-8.41
-2.84
-10.80
4.74
5.54
Adjusted Book Value (₹) info
--
-18.33
-7.21
-1.62
12.70
11.92
Dividend per Share (₹) info
--
--
--
--
--
--
Cash Flow per Share (₹) info
--
-6.30
-1.75
-0.52
0.89
2.00
Free Cash Flow per Share (₹) info
--
-4.19
-5.69
-4.67
-1.52
-1.95

Profitability Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
ROCE (%) info
--
-76.70
-29.88
-59.76
3.96
6.62
ROE (%) info
--
--
--
-277.44
-2.26
3.38
ROA (%) info
3.80
-18.60
-12.36
-34.91
-0.58
0.70
EBIT Margin (%) info
-13.66
-38.41
-2.76
-45.97
2.46
3.44
Net Margin (%) info
3.31
-34.21
-7.41
-51.80
-0.67
0.77
Cash Profit Margin (%) info
--
-25.97
-3.77
-36.54
11.50
11.36

Growth Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Revenue Growth (%) info
76.89
-57.06
155.17
-28.23
-15.57
-30.31
EBIT Growth (%) info
-24.39
-498.76
84.71
-1,438.89
-39.45
-57.49
Net Profit Growth (%) info
127.53
-98.62
63.59
-5,425.72
-173.54
-81.24
EPS Growth (%) info
120.68
-98.62
63.59
-5,424.95
-173.56
-81.24
Book Value Growth (%) info
--
-154.12
-346.40
-112.73
6.55
13.72

Valuation Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Price / Earnings info
87.92
--
--
--
--
108.00
Price / Book Value info
11.44
-1.55
-5.86
-17.63
2.39
3.43
Dividend Yield (%) info
--
--
--
--
--
--
EV/EBITDA info
46.49
-6.14
80.88
-4.97
7.10
7.40
Close Price (₹) info
137.75
28.44
42.24
28.48
30.36
40.85
High Price (₹) info
137.75
55.02
54.00
36.58
57.60
81.90
Low Price (₹) info
22.60
22.60
25.03
24.18
26.35
33.10
Market Cap (₹ Cr) info
92.93
10.64
15.80
10.66
11.36
15.28

Solvency Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Debt to Equity info
1.18
-1.96
-4.07
56.07
0.98
1.00
Short term debt to equity ratio info
--
--
--
--
--
--
Current Ratio info
1.41
0.74
0.69
0.63
1.06
0.90
Quick Ratio info
1.13
0.39
0.43
0.37
0.45
0.51
Interest Coverage info
0.49
-3.71
-3.09
-8.08
1.12
1.78

Operating Efficiency Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Debtors to sales (%) info
41.75
26.11
4.53
16.43
4.04
3.71
Asset Turnover info
0.99
0.54
1.66
0.67
0.87
0.90
Receivable days info
--
66.89
20.01
40.27
15.38
23.31
Inventory Days info
--
168.22
36.94
110.64
84.70
68.05
Payable days info
--
453.49
149.20
311.96
338.42
419.72
Cash Conversion Cycle info
--
-218.39
-92.25
-161.05
-238.34
-328.36
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...